Table 3. Effect of IVM on pharyngeal pumping activity of wild-type, nhr-8 deficient and transgenic C. elegans strains.
Pump frequency (Hz) | |||
---|---|---|---|
Untreated | IVM 0.1 μM | IVM ratio | |
Bristol N2 | 4.5 ± 0.1 | 2.1. ± 0.2 a | 2.4 |
AE501 nhr-8(ok186) | 4.4 ± 0.1 | 0.3 ± 01 a, b | 13.0 |
Cel-nhr-8 in AE501 | 4.5 ± 0.1 | 2.0 ± 0.1 a | 2.2 |
Cel-pgp-6 in AE501 | 4.2 ± 0.1 | 2.4 ± 0.2 a | 1.8 |
Hco-nhr-8 in AE501 | 4.6 ± 0.1 | 2.1 ± 0.2 a | 2.1 |
Pump frequency recorded with the Nemametrix ScreenChip system. Mean ± SEM; n = 30–90 worms/group.
IVM potency ratio as pump frequency with no treatment / pump frequency following exposure with IVM at 0.1 μM.
a p<0.001 vs untreated worms;
b p<0.001 vs wild-type Bristol N2.